Birmingham University spinout secures £2m for eye disease treatment
Healome Therapeutics has become the first West Midlands business to receive investment through Midlands Mindforge, a capital investment company founded by eight of the region's universities.
The University of Birmingham spinout is developing an advanced eye drop technology. It forms a soft layer that liquefies with each blink to lubricate the eye, then reforms as a protective layer.
The technology could benefit people with Epidermolysis Bullosa, a group of rare, inherited skin disorders... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
